AIG Hospital

What AIG Hospital does

AIG Hospital, operating as Asian Institute of Gastroenterology Private Limited, is a privately held multi-specialty hospital chain headquartered in Hyderabad, India, founded in 1986 and led by Chairman Dr. D. Nageshwar Reddy. It runs three facilities in Hyderabad — Gachibowli, Banjara Hills, and Somajiguda — covering 40+ medical specialties including gastroenterology, neurology, oncology, organ transplantation, and interventional radiology. The hospital has treated over 1 million patients cumulatively, holds NABH, JCI, NABL, and ISO 9001 certifications, and is ranked 17th globally among Centres of Excellence. Its International Patient Services programme serves patients from more than 50 countries with end-to-end medical tourism support.

The hospital's technology stack centres on advanced clinical platforms: the ZAP-X Gyroscopic Neuro-Radiosurgery Platform (first in South India) for non-invasive brain tumor treatment; endoscopic keyhole spine surgery techniques; robotic and minimally invasive surgery; and a gut microbiome research centre at the Gachibowli campus. In October 2025 it launched India's first affordable NGS-based pharmacogenomics test at Rs. 5,000 (~94% below the global average of ~Rs. 80,000) in partnership with GenepoweRx, and is pursuing government integration at Rs. 2,000–3,000 per person. Digital patient engagement is delivered through the AIG Mitr mobile app, and the hospital collaborates with ICMR (digital health research), Terumo India (Centre of Excellence for Interventional Radiology), and international universities (Luxembourg, Marburg) on translational research.

Revenue is generated primarily from clinical services across 40+ specialties at the three Hyderabad hospitals, with supplementary streams from international patient services (professional-services-style logistics and care packages), diagnostic testing (pay-per-test pharmacogenomics), and recurring preventive health check-up packages. Pricing for most services is quote-based; the pharmacogenomics test is unit-priced at Rs. 5,000 with results in 12 days. Capital history includes a 2019 Series D of approximately $42.3M led by PG Impact Investments and Quadria Capital, with prior backing from Samara Capital (2014) and Quadria Capital (2015). The promoter family also operates an investment office that participated in Recykal's $23M bridge round ($9M) in June 2026.

Name

AIG Hospital

Legal name

Asian Institute of Gastroenterology Private Limited

Website

https://aighospitals.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

AIG Hospital is a Hyderabad-based, JCI- and NABH-accredited multi-specialty hospital chain founded in 1986, operating three facilities across 40+ specialties, serving over 1 million cumulative patients including international patients from 50+ countries under Chairman Dr. D. Nageshwar Reddy.

Ownership category

akta.pro rank

Product category

Multi-Specialty Hospital Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Ambulatory Specialty Clinics (Multi-Specialty & Single-Specialty) (HLAFABAA)

akta.pro secondary industry

Community & Regional General Hospitals (HLAFAAAB)

Keywords

• Multi-specialty hospital
• Gastroenterology services
• Neurosurgery treatments
• Preventive health packages
• International patient care

Headquarters

HQ city

Hyderabad

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Clinical Services Revenue: Revenue generated from patient consultations, treatments, and procedures across 40+ medical specialties at three hospital locations in Hyderabad (Gachibowli, Banjara Hills, Somajiguda).
2. International Patient Services: Specialized services for international patients including visa assistance, accommodation, interpreter services, and medical travel coordination across 50+ countries.
3. Diagnostic Testing: Specialized diagnostic services including pharmacogenomics testing (DNA-based prescription tailoring) priced at Rs. 5,000 per test, with potential for integration into public health programs at Rs. 2,000-3,000 per person.
4. Health Packages: Preventive health check-up packages and screening services offered to patients.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

AIG Hospitals operates as a multi-specialty hospital chain in Hyderabad, India, providing clinical care across 40+ medical specialties including gastroenterology, neurosurgery, oncology, transplant services, and minimally invasive surgery. The hospital runs three facilities (Gachibowli, Banjara Hills, Somajiguda) and complements clinical services with advanced diagnostic offerings such as pharmacogenomics testing, the ZAP-X radiosurgery platform for brain tumors, and a gut microbiome research centre.

Product overview

AIG Hospitals operates as a multi-speciality hospital network with 40+ medical specialties across two locations in Hyderabad (Banjara Hills and Gachibowli). The core offering is clinical care supported by specialized technology platforms including the ZAP-X radiosurgery system for brain tumors, pharmacogenomics testing for personalized medicine, and a dedicated microbiome research centre. Digital services are delivered through the AIG Mitr mobile app, while health checkup packages and international patient services extend accessibility. Research collaborations with ICMR and Terumo's Centre of Excellence enhance clinical capabilities, treating patients from 50+ countries worldwide.

Differentiator

Problem solved

Functional benefit

Brands

• AIG Mitr: Mobile application that brings the entire hospital experience to smartphones, enabling appointment booking and health record access.

Products and services

• ZAP-X Gyroscopic Neuro-Radiosurgery Treatment Non-invasive radiosurgery treatment for brain tumor patients using the ZAP-X Gyroscopic Neuro-Radiosurgery Platform (first installation in South India), completing treatment in 30-45 minutes per session.
• Pharmacogenomics Testing Service DNA-based diagnostic test using Next-Generation Sequencing technology that analyzes genetic profiles to personalize drug prescriptions for heart disease, diabetes, cancer, and other disorders. Priced at Rs. 5,000 with results delivered within 12 days.
• Health Checkup Packages Preventive health assessment packages offered across multiple specializations for early detection and wellness management, bookable through the hospital website.
• International Patient Services Comprehensive services for international patients from 50+ countries including airport transfers, visa assistance, interpreter services, insurance coordination, and medical travel guides.
• AIG Mitr Mobile App Mobile application enabling appointment booking, health records access, and remote consultations for patients of AIG Hospitals.
• Endoscopic Keyhole Spine Surgery Minimally invasive endoscopic surgery for slipped disc treatment offering faster recovery, smaller incisions, and reduced post-operative discomfort, with selected patients able to walk on the same day.
• Multi-Specialty Clinical Services Inpatient and outpatient clinical services across 40+ medical specialties including gastroenterology, neurology, oncology, cardiology, transplant services, and organ transplantation at three Hyderabad locations.

Quantifiable outcome

• ZAP-X system can treat 6 patients daily with potential to expand to 3,000 patients annually
• +2 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core, flagship and minor.

• Terumo IndiacoreStrategic or Co-development Partner · 22 April 2026Terumo India and AIG Hospitals signed an MoU to establish a Centre of Excellence for Interventional Radiology in India under Terumo's 'Elevate IR' programme. AIG Hospitals serves as the first training centre offering simulation-based training, expert-led sessions, and case-based discussions supported by the Terumo India Skill Lab. The collaboration aims to improve clinical outcomes, reduce procedural risks, and expand access to advanced minimally invasive treatments across India.
• Indian Council of Medical Research (ICMR)flagshipStrategic or Co-development Partner · 12 April 2026AIG Hospitals signed an MoU with ICMR to collaborate on digital health innovation, healthcare management, and translational medicine research. Both institutions will conduct joint research studies, co-develop grant proposals for national and international funding, and facilitate knowledge and data exchange while adhering to regulatory and ethical frameworks. The collaboration leverages AIG Hospitals' clinical expertise and ICMR's national health research leadership.
• University of Luxembourg and University of MarburgminorStrategic or Co-development Partner · 27 February 2026AIG Hospitals collaborated with University of Luxembourg and University of Marburg on a research study analyzing genetic data from 6,663 Indians in the UK Biobank and 91 India-based participants to study obesity risk factors and lifestyle interventions.
• Young India Skills UniversityminorStrategic or Co-development Partner · 31 December 2025AIG Hospitals partnered with Young India Skills University under a public-private partnership model. The university, supported by Telangana government with CM Revanth Reddy as chancellor, includes AIG Hospitals among corporate partners providing internships and job opportunities in healthcare.
• GenepoweRxcoreTechnology or Integration · 23 October 2025AIG Hospitals in collaboration with GenepoweRx launched India's first affordable pharmacogenomics test using Next-Generation Sequencing technology. The DNA-based test analyzes how genes influence responses to drugs for heart disease, diabetes, cancer, and other disorders. AIG is in discussions with the Indian government to integrate genetic testing into public health programmes.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• KIMS Hospitals (Krishna Institute of Medical Sciences): Hyderabad-headquartered multi-specialty tertiary-care chain with a strong South India footprint and listed public market valuation. The closest geographic and operating-model comparable to AIG, including a similar mix of complex tertiary care and self-pay patients.
• Yashoda Hospitals: Hyderabad-headquartered multi-specialty tertiary-care hospital group with comparable footprint size and specialty depth. Most directly comparable on city-level operating environment and patient mix in AIG's home market.
• Narayana Health: Multi-specialty hospital chain with a strong affordable-care and complex-surgery model, founded by Dr. Devi Shetty. Comparable on tertiary-care complexity, multi-specialty breadth and India-specific affordable-innovation positioning.
• Medanta (Global Health): Multi-specialty tertiary-care hospital group led by Dr. Naresh Trehan with super-specialty depth, medical-tourism focus and research-driven positioning. Directly comparable on tertiary-care complexity, advanced technology adoption and international patient acquisition.
• Care Hospitals (Quality Care India): Multi-specialty hospital group with strong South India / Hyderabad presence and tertiary-care capability. Closely comparable on geography, specialty mix and tertiary-care positioning.

Broad incumbents

• Fortis Healthcare: Large national multi-specialty chain with significant tertiary-care and quaternary-care capability. Comparable on multi-specialty service mix and advanced-technology adoption; broader geographic footprint than AIG.
• Max Healthcare: North-India-heavy multi-specialty hospital chain with strong tertiary and quaternary care capabilities and listed-equity comparables. Comparable on specialty depth and accreditation standards; less geographic overlap with AIG.
• Manipal Hospitals: Pan-India multi-specialty hospital chain with strong South India presence and broad specialty coverage. Comparable on multi-specialty operating model and tertiary-care complexity, though at materially larger scale.
• Apollo Hospitals Enterprise: India's largest multi-specialty hospital chain with pan-India presence. Directly comparable to AIG on multi-specialty depth, JCI-accredited tertiary care and international patient services, but operates at substantially greater scale and geographic breadth.

Regional players

• Continental Hospitals: Hyderabad-based multi-specialty tertiary-care hospital with comparable specialty mix and JCI-level accreditation. Smaller scale than AIG but directly competes for the same Hyderabad patient pool.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AIGHospitals

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AIG Hospital